Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$4,088,354
+$88,290 QoQ
Shares Held
26,087
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#301
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NAPLES GLOBAL ADVISORS, LLC holds $87,787,212 across 12 Drug Manufacturers - General names. NVS ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,798 | $15,350,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
106,535 | $13,689,747 | |
| 3 | JNJ |
Johnson & Johnson
|
52,184 | $13,253,170 | |
| 4 | AMGN |
Amgen Inc
|
35,170 | $12,735,760 | |
| 5 | ABBV |
AbbVie Inc.
|
48,122 | $12,109,420 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
89,358 | $5,148,807 | |
| 7 | AZN |
Astrazeneca PLC
|
24,721 | $4,687,596 | |
| 8 | NVS |
Novartis AG
This page
|
26,087 | $4,088,354 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,088,354 | 26,087 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $4,000,064 | 26,187 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $3,602,543 | 26,130 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $3,372,712 | 26,300 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $3,247,303 | 26,835 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,036,046 | 27,234 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,725,555 | 28,009 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $3,227,346 | 28,059 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,995,677 | 28,139 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,750,517 | 28,435 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,862,398 | 28,349 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $2,918,187 | 28,649 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,928,811 | 29,024 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $2,704,708 | 29,399 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $2,662,087 | 29,344 | Shares | Sole | 2023-04-17 | |
| 2022-09-30 | $2,196,232 | 28,894 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,345,200 | 27,744 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,331,342 | 26,568 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,286,290 | 26,138 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,104,035 | 25,728 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,295,963 | 25,164 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,071,522 | 24,234 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,256,310 | 23,894 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,876,509 | 21,579 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,723,916 | 19,738 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $1,610,083 | 19,528 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||